GUD.TO
Knight Therapeutics Inc
Price:  
5.40 
CAD
Volume:  
52,478.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GUD.TO Intrinsic Value

86.20 %
Upside

As of 2024-02-22, the Intrinsic Value of Knight Therapeutics Inc (GUD.TO) is 10.06 CAD. This GUD.TO valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 5.40 CAD, the upside of Knight Therapeutics Inc is 86.20%.

The range of the Intrinsic Value is 7.03 - 14.43 CAD

5.40 CAD
Stock Price
10.06 CAD
Intrinsic Value
Intrinsic Value Details

GUD.TO Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) (64.09) - (18.23) (27.94) -617.4%
DCF (Growth 10y) (15.01) - (45.68) (21.57) -499.4%
DCF (EBITDA 5y) 7.03 - 14.43 10.06 86.2%
DCF (EBITDA 10y) 11.99 - 27.85 18.32 239.3%
Fair Value -0.37 - -0.37 -0.37 -106.83%
P/E (0.00) - (0.01) (0.00) -100.1%
EV/EBITDA 5.85 - 10.09 7.23 34.0%
EPV (1.15) - (1.51) (1.33) -124.7%
DDM - Stable (1.07) - (23.11) (12.09) -323.9%
DDM - Multi (3.91) - (66.19) (7.40) -237.1%

GUD.TO Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 563.55
Beta 0.26
Outstanding shares (mil) 104.36
Enterprise Value (mil) 568.15
Market risk premium 5.10%
Cost of Equity 6.56%
Cost of Debt 19.57%
WACC 7.57%